Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBN Tablets in Type 2 Diabetic Nephropathy
CTR20210206Phase 2Completed
- Sponsor
- Guangzhou Magpie Pharmaceutical
- Start
- Feb 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetramethylpyrazine nitrone in diabetic glomerulosclerosis, type 2 diabetes mellitus (T2DM), sponsored by Guangzhou Magpie Pharmaceutical. Started Feb 2021; status: completed.
02
Drugs
tetramethylpyrazine nitrone
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20210206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210206.